Natco Pharma Promoters Acquire Equity Shares via Rights Issue Allotment
Natco Pharma Ltd 路 Acquisition/ Disposal of Shares 路 30 Oct 2026, 4:12 pm
Natco Pharma Promoters Acquire Equity Shares via Rights Issue Allotment Natco Pharma Limited disclosed share acquisitions by promoter and promoter group entities pursuant to a rights issue allotment on 26th Oct'26. Consequently, the company's total paid-up equity capital increased from 17,91,09,870 shares to 19,61,67,952 shares of Rs. 2 each. Key promoter allotments included Time Cap Pharma Labs (9,33,333 shares; 9.23% post-issue stake), Venkaiah Chowdary Nannapaneni (5,86,666 shares; 14.60%), Neelima Sita Nannapaneni (2,55,387 shares), Natsoft Information Systems (2,40,000 shares; 8.17%), and Venkata Satya Swathi Kantamani (61,333 shares; 8.15%), among other participating group trusts and entities.
Original exchange filing (PDF)
More announcements from Natco Pharma Ltd
- Intimation of Investor Meet 路 17 Nov 2026
- Audio link of Earnings Conference Call Q2FY27 路 14 Nov 2026
- Q2 FY27 Earnings Presentation 路 13 Nov 2026
- Un audited Financial Results for the quarter and half year ended 30th September, 2026 路 13 Nov 2026
- 19th November, 2026 is the Record Date for the payment of 2nd Interim Dividend for FY 2026-27 路 13 Nov 2026
- Natco Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026 and declaration of 2nd Interim Dividend for FY 2026-27 路 13 Nov 2026
- Outcome of Board Meeting 路 13 Nov 2026
- Intimation of schedule of Concall 路 13 Nov 2026
